SEC Filings TLDR

Sphera Funds Management Ltd., along with Sphera Global Healthcare GP Ltd. and Sphera Global Healthcare Management LP, has filed an amendment to its Schedule 13G, disclosing an increased ownership in ProMIS Neurosciences Inc. The filing indicates that Sphera Funds Management Ltd. now holds 3,122,090 common shares, repre...

Lightspeed China Partners III, L.P., Lightspeed China Partners Select I, L.P., and other related entities have filed an amendment to their Schedule 13G, indicating that they have ceased to be beneficial owners of more than five percent of the outstanding shares of Hesai Group. The filing details the ownership percentag...

Vaughan Nelson Investment Management, L.P. and its General Partner, Vaughan Nelson Investment Management, Inc., filed an amendment to their Schedule 13G/A for Cushman & Wakefield plc. The filing reports a 4.46% ownership of the company's common stock, totaling 10,320,243 shares. The shares are held by various investmen...

ArrowMark Colorado Holdings LLC has filed an amendment to its Schedule 13G, disclosing an increased stake in CarGurus, Inc. The filing, dated October 23, 2025, reveals that ArrowMark now holds 3,743,449 shares of CarGurus' Class A Common Stock, representing a 4.42% ownership. This marks an increase in the value of the ...

FITTERS Diversified Berhad, a Malaysian company, filed an amendment to its Schedule 13G/A for Bio Green Med Solution, Inc. The filing indicates that FITTERS Diversified Berhad beneficially owns 279,248 shares of Bio Green Med Solution, Inc., representing 7.98% of the common stock. The shares are held with sole voting a...

ArrowMark Colorado Holdings LLC filed an amendment to its Schedule 13G for 8X8 Inc., reporting ownership of 2,604,788 shares of common stock, representing 1.93% of the total shares outstanding. The filing indicates that ArrowMark Colorado Holdings LLC has sole voting and dispositive power over these shares. The amendme...

Wells Fargo & Company has filed an amendment to its Schedule 13G, disclosing an increased stake in Voya Emerging Markets High Dividend Eq. The filing, dated October 22, 2025, reveals that Wells Fargo now owns 802,366 common shares, representing a 4.5% ownership in the company. This marks an increase of 320,312 shares, ...

Wells Fargo & Company has filed a Schedule 13G/A amendment, reporting a reduction in its stake in Virtus Diversified Inc & Conv Fund. The filing indicates that Wells Fargo now holds 482,054 common shares, representing a 4.6% ownership stake, down from a previous holding of 823,572 shares. This represents a decrease of ...

Wells Fargo & Company has filed an amendment to its Schedule 13G/A for BlackRock MuniYield PA Quality, reporting a decrease in its ownership. The filing indicates that Wells Fargo & Company now holds 823,572 common shares of beneficial interest, representing 6.4% ownership. This is a decrease of 92,690 shares from the ...

Wells Fargo & Company has filed an amendment to its Schedule 13G/A for Ellsworth Growth and Income, reporting a decrease in its beneficial ownership. The filing indicates that Wells Fargo & Company now holds 916,262 common shares of beneficial interest, representing 6.7% of the total shares. This marks a significant de...

Wells Fargo & Company has filed a Schedule 13G/A amendment, disclosing an increased ownership of 4,014,179 common shares of BlackRock Resources & Commodity, representing a 5.3% stake. The filing indicates that Wells Fargo & Company, along with its subsidiaries Wells Fargo Advisors Financial Network, LLC and Wells Fargo...

Wells Fargo & Company has filed an amendment to its Schedule 13G, reporting an increased ownership of 7.8% in Ares Dynamic Credit Allocation Fund. The filing indicates that Wells Fargo & Company now beneficially owns 1,792,520 common shares of the fund. The shares are held in the ordinary course of business and not for...

Christopher M. Plahm, through Tall Pines Capital, LLC and Stonebridge Wealth Management, LLC, filed an amendment to Schedule 13G for United Homes Group, Inc. The filing reports beneficial ownership of 1,777,002 shares of common stock, representing 8.216% of the total. Tall Pines Capital, LLC owns 1,274,192 shares (5.89...

Aaron Allred, a United States citizen, has filed an amendment to Schedule 13G/A for Upbound Group Inc. The filing discloses that Allred, through Alterra Holdings, LLC and Arklow Holdings, LLC, has beneficial ownership of 4,101,233 shares of Common Stock, representing 7.1% of the total outstanding shares. Allred has sol...

Royce & Associates LP has filed a Schedule 13G/A amendment with the SEC, disclosing a reduction in its stake in Silvercrest Asset Management Group Inc. As of September 30, 2025, Royce & Associates LP owns 385,002 shares of Class A Common Stock, representing a 4.56% ownership stake. This marks a decrease of 183,291 shar...

Royce & Associates LP has filed a Schedule 13G/A amendment with the SEC, disclosing an increased stake in Seneca Foods Corporation. As of September 30, 2025, Royce & Associates LP beneficially owns 261,703 shares of Seneca Foods' Class A Common Stock, representing 4.94% of the outstanding shares. The shares are valued ...

Royce & Associates LP has filed an amendment to its Schedule 13G, disclosing a reduction in its stake in Stoneridge, Inc. As of September 30, 2025, Royce & Associates LP owns 1,035,697 shares of Stoneridge, Inc., representing a 3.7% ownership stake. This marks a decrease of 362,900 shares, or 25.9474%, from its previou...

Royce & Associates LP has filed an amendment to its Schedule 13G for Standard Motor Products, Inc., reporting ownership of 1,064,511 shares, representing 4.84% of the company's common stock. The filing indicates a decrease of 251,449 shares from the previous report, reflecting a 19.11% reduction in ownership. The value...

Johnson & Johnson and its subsidiary Johnson & Johnson Innovation-JJDC, Inc. have filed Amendment No. 1 to Schedule 13G, reporting their ownership of 1,784,517 shares of Common Stock in Rapport Therapeutics, Inc., representing 4.9% ownership. The filing indicates a decrease of 713,534 shares compared to the previous re...

Royce & Associates LP has filed an amendment to its Schedule 13G, disclosing a reduction in its ownership stake in Resources Connection, Inc. (RGP). As of September 30, 2025, Royce & Associates LP owns 700,776 shares, representing 2.1% of the company's common stock. This marks a significant decrease from its previous h...

Royce & Associates LP filed an amendment to its Schedule 13G/A for Kopin Corporation, reporting ownership of 7,618,677 shares, representing 4.68% of the company's common stock. The filing indicates that Royce & Associates LP has sole voting and dispositive power over these shares. The amendment reflects a decrease of 6...

Johnson & Johnson (J&J) and its wholly-owned subsidiary, Johnson & Johnson Innovation-JJDC, Inc. (JJDC), have filed an Amendment No. 1 to Schedule 13G for Rapport Therapeutics, Inc. The amendment reports that J&J and JJDC beneficially own 1,784,517 shares of Rapport Therapeutics' common stock, representing 4.9% of the ...

Royce & Associates LP has filed a Schedule 13G/A amendment, disclosing an increased stake in Identiv, Inc. The filing indicates that Royce & Associates LP now owns 1,111,476 shares, representing 4.69% of the company's common stock. The shares are valued at approximately $3,356,657.52. The filing also clarifies that the...

Royce & Associates LP has filed an amendment to its Schedule 13G, reporting its ownership of 1,111,476 shares of Identiv, Inc.'s common stock, representing 4.69% of the total shares outstanding. The filing indicates a decrease of 103,617 shares from the previous report, reflecting an 8.53% reduction in ownership. The t...

Royce & Associates LP has filed a Schedule 13G/A amendment, disclosing a significant reduction in its stake in Forrester Research, Inc. The filing indicates that Royce & Associates LP now holds 106,387 shares, representing a 0.56% ownership stake in the company. This marks a substantial decrease from its previous holdi...